In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Health officials have set targets for how good and how safe a COVID-19 vaccine needs to be, but communicating that to the public can present challenges.

Italian authorities have arrested a Chinese man accused by US prosecutors of being part of a hacking team that stole coveted ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease ...

Karnataka Chief Minister Siddaramaiah had suggested that the recent heart attack deaths in the Hassan district might be linked to the COVID vaccination drive. He had also claimed the vaccines were ...

Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic ...